Modulation of forskolin-mediated adenylyl cyclase activation by constitutively active G(s)-coupled receptors

FEBS Letters

Volumn 419, Issue 2-3, 1997, Pages 171-174

  Alewijnse, Astrid E ^a   Smit, Martine J ^a   Sol Rodriguez Pena, M ^a   Verzijl, Dennis ^a   Timmerman, Henk ^a   Leurs, Rob ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Constitutive activity; Forskolin; G protein coupled receptor; Histamine H2 receptor; Inverse agonism; TSH receptor

Indexed keywords

ADENYLATE CYCLASE; FORSKOLIN; GUANINE NUCLEOTIDE BINDING PROTEIN; HISTAMINE H2 RECEPTOR; THYROTROPIN RECEPTOR;

ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; ENZYME ACTIVATION; MODULATION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADENYLATE CYCLASE; ANIMALS; CHO CELLS; COS CELLS; CRICETINAE; ENZYME ACTIVATION; FORSKOLIN; GENE EXPRESSION REGULATION; GTP-BINDING PROTEINS; RECEPTORS, HISTAMINE H2; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 0031435704     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(97)01440-3     Document Type: Article

References (33)

1. Milligan G., Bond R.A., Lee M. Trends Pharmacol. Sci. 16:1995;10-13.
2. Lefkowitz R.L., Cotecchia S., Samama P., Costa T. Trends Pharmacol. Sci. 14:1993;303-307.
3. Costa T., Ogino Y., Munson P.J., Onaran O., Rodbard D. Mol. Pharmacol. 41:1992;549-560.
4. Schütz W., Freissmuth M. Trends Pharmacol. Sci. 13:1992;376-380.
5. Scheer A., Cotecchia S. J. Recept. Signal Transduct. Res. 17:1997;57-73.
6. Spiegel A.M. Annu. Rev. Physiol. 58:1996;143-170.
7. Perlman S., et al. Mol. Pharmacol. 51:1997;301-311.
8. Claude P.A., Wotta D.R., Zhang X.H., Prather P.L., McGinn T.M., Erickson L.J., Loh H.H., Law P.Y. Proc. Natl. Acad. Sci. USA. 93:1996;5715-5719.
9. Adie E.J., Milligan G. Biochem. J. 303:1994;803-808.
10. MacEwan D.J., Milligan G. FEBS Lett. 399:1996;108-112.
11. Jinsi-Parimoo A., Gershengorn M.C. Endocrinology. 138:1997;1471-1475.
12. Quitterer U., Abdalla S., Jarnagin K., Mulleresterl W., Costa T., Lefkowitz R.J. Biochemistry. 35:1996;13368-13377.
13. Cetani F., Tonacchera M., Vassart G. FEBS Lett. 378:1996;27-31.
14. Burstein E.S., Spalding T.A., Braüner-Osborne H., Brann M.R. FEBS Lett. 363:1995;261-263.
15. Mullaney I., Carr I.C., Milligan G. FEBS Lett. 397:1996;325-330.
16. Daly J.W., Padgett W., Seamon K.B. J. Neurochem. 38:1982;532-544.
17. Sutkowski E.M., Tang W.J., Broome C.W., Robbins J.D., Seamon K.B. Biochemistry. 33:1994;12852-12859.
18. Smit M.J., Leurs R., Alewijnse A.E., Blauw J., van Nieuw Amerongen G.P., van de Vrede Y., Roovers E., Timmerman H. Proc. Natl. Acad. Sci. USA. 93:1996;6802-6807.
19. Sterk G.J., van der Goot H., Timmerman H. Eur. J. Med. Chem. 22:1987;427-432.
20. Smit M.J., Roovers E., Timmerman H., van de Vrede Y., Alewijnse A.E., Leurs R. J. Biol. Chem. 271:1996;7574-7582.
21. Smit M.J., Timmerman H., Alewijnse A.E., Punin M., van den Nieuwenhof I., Blauw J., van Minnen J., Leurs R. Biochem. Biophys. Res. Commun. 214:1995;1138-1145.
22. Beukers M.W., Klaassen C.H.W., de Grip W.J., Verzijl D., Timmerman H., Leurs R. Br. J. Pharmacol. 122:1997;867-874.
23. Brakenhoff R.H., Knippels E.M., van Dongen G.A. Anal. Biochem. 218:1994;460-463.
24. Leurs R., Smit M.J., Menge W.M.B.P., Timmerman H. Br. J. Pharmacol. 112:1994;847-854.
25. Bradford M.M. Anal. Biochem. 72:1976;248-254.
26. Parma J., Duprez L., Van Sande J., Cochaux P., Gervy C., Mockel J., Dumont J., Vassart G. Nature. 365:1993;649-651.
27. Maenhaut C., et al. Biochem. Biophys. Res. Commun. 173:1990;1169-1178.
28. Chidiac P., Hebert T.E., Valiquette M., Dennis M., Bouvier M. Mol. Pharmacol. 45:1994;490-499.
29. Takuma T. Biochim. Biophys. Acta. 1052:1990;461-466.
30. Mewes T., Dutz S., Ravens U., Jakobs K.H. Circulation. 88:1993;2916-2922.
31. Götze K., Jakobs K.H. Eur. J. Pharmacol. 268:1994;151-158.
32. Chiu T.T., Yung L.Y., Wong Y.H. Mol. Pharmacol. 50:1996;1651-1657.
33. Griffon N., Pilon C., Sautel F., Schwartz J.C., Sokoloff P. J. Neural Transm. 103:1996;1163-1175.